The EMT universe: Space between cancer cell dissemination and metastasis initiation

Critical Reviews in Oncogenesis

Volumn 19, Issue 5, 2014, Pages 349-361

  Ombrato, Luigi ^a   Malanchi, Ilaria ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Epithelial To Mesenchymal Transition (Emt); Mesenchymal To Epithelial transition (MET); Metastasis; Stemness

Indexed keywords

ARTICLE; BLOOD; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CANCER STEM CELL; CELL DEDIFFERENTIATION; CELL HETEROGENEITY; CELL INVASION; CELL SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; LYMPH VESSEL; MALIGNANT TRANSFORMATION; MECHANICS; MESENCHYME; METASTASIS; NONHUMAN; PHENOTYPE; PLASTICITY; STEMNESS; CELL DIVISION; NEOPLASM; PATHOLOGY;

CELL DIVISION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84908154922     PISSN: 08939675     EISSN: 21626448     Source Type: Journal    
DOI: 10.1615/CritRevOncog.2014011802     Document Type: Article

References (68)

1. Thiery, JP, Sleeman, JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–42.
2. Thiery, JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.
3. Tsai, JH, Yang, J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192–206.
4. Garber, K. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J Natl Cancer Inst. 2008;100:232–9.
5. Ledford, H. Cancer theory faces doubts. Nature. 2011;472:273.
6. Entenberg, D, Kedrin, D, Wyckoff, J, Sahai, E, Condeelis, J, Segall, JE. Imaging tumor cell movement in vivo. Curr Protoc Cell Biol. 2013;Chapter 19:Unit19.7.
7. Yu, M, Bardia, A, Wittner, BS, Stott, SL, Smas, ME, Ting, DT, Isakoff, SJ, Ciciliano, JC, Wells, MN, Shah, AM, Concannon, KF, Donaldson, MC, Sequist, LV, Brachtel, E, Sgroi, D, Baselga, J, Ramaswamy, S, Toner, M, Haber, DA, Maheswaran, S. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339:580–4.
8. Theveneau, E, Marchant, L, Kuriyama, S, Gull, M, Moepps, B, Parsons, M, Mayor, R. Collective chemotaxis requires contact-dependent cell polarity. Dev Cell. 2010;19:39–53.
9. Theveneau, E, Mayor R. Neural crest delami-nation and migration: From epithelium-to-mesenchyme transition to collective cell migration. Dev Biol. 2012;366:34–54.
10. Leroy, P, Mostov, KE. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell. 2007;18:1943–52.
11. Giampieri, S, Manning, C, Hooper, S, Jones, L, Hill, CS, Sahai, E. Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol. 2009;11:1287–96.
12. Xu, J, Lamouille, S, Derynck, R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156–72.
13. Labelle, M, Begum, S, Hynes, RO. Direct signaling between platelets and cancer cells in-duces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576–90.
14. Kalluri, R, Weinberg, RA. The basics of epi-thelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8.
15. Acloque, H, Adams, MS, Fishwick, K, Bronner-Fraser, M, Nieto, MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119:1438–49.
16. Brabletz, T. EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell. 2012;22:699–701.
17. Yu, Y, Xiao, CH, Tan, LD, Wang, QS, Li, XQ, Feng, YM. Cancer-associated fbroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling. Br J Cancer. 2014;110:724–32.
18. Thiery, JP, Acloque, H, Huang, RYJ, Nieto, MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
19. Huber, MA, Azoitei, N, Baumann, B, Grünert, S, Sommer, A, Pehamberger, H, Kraut, N, Beug, H, Wirth, T. NF-κB is essential for epithelial-mes-enchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114:569–81.
20. Rhim, AD, Mirek, ET, Aiello, NM, Maitra, A, Bailey, JM, McAllister, F, Reichert, M, Be-atty, GL, Rustgi, AK, Vonderheide, RH, Leach, SD, Stanger, BZ. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349–61.
21. Yang, MH, Wu, MZ, Chiou, SH, Chen, PM, Chang, SY, Liu, CJ, Teng, SC, Wu, KJ. Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol. 2008;10:295–305.
22. Uhlén, M, Björling, E, Agaton, C, Szigyarto, CA, Amini, B, Andersen, E, Andersson, AC, An-gelidou, P, Asplund, A, Asplund, C, Berglund, L, Bergström, K, Brumer, H, Cerjan, D, Ekström, M, Elobeid, A, Eriksson, C, Fagerberg, L, Falk, R, Fall, J, Forsberg, M, Björklund, MG, Gumbel, K, Halimi, A, Hallin, I, Hamsten, C, Hansson, M, Hedhammar, M, Hercules, G, Kampf, C, Lars-son, K, Lindskog, M, Lodewyckx, W, Lund, J, Lundeberg, J, Magnusson, K, Malm, E, Nilsson, P, Odling, J, Oksvold, P, Olsson, I, Oster, E, Ot-tosson, J, Paavilainen, L, Persson, A, Rimini, R, Rockberg, J, Runeson, M, Sivertsson, A, Sköller-mo, A, Steen, J, Stenvall, M, Sterky, F, Strömberg, S, Sundberg, M, Tegel, H, Tourle, S, Wahlund, E, Waldén, A, Wan, J, Wernérus, H, Westberg, J, Wester, K, Wrethagen, U, Xu, LL, Hober, S, Pon-tén, F. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920–32.
23. Uhlen, M, Oksvold, P, Fagerberg, L, Lundberg, E, Jonasson, K, Forsberg, M, Zwahlen, M, Kampf, C, Wester, K, Hober, S, Wernerus, H, Björling, L, Ponten, F. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28:1248–50.
24. Burrell, RA, McGranahan, N, Bartek, J, Swan-ton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338–45.
25. Hermann, PC, Huber, SL, Herrler, T, Aicher, A, Ellwart, JW, Guba, M, Bruns, CJ, Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313–23.
26. Cho, RW, Wang, X, Diehn, M, Shedden, K, Chen, GY, Sherlock, G, Gurney, A, Lewicki, J, Clarke, MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells. 2008;26:364–71.
27. Schatton, T, Murphy, GF, Frank, NY, Yamaura, K, Waaga-Gasser, AM, Gasser, M, Zhan, Q, Jordan, S, Duncan, LM, Weishaupt, C, Fuhlbrigge, RC, Kupper, TS, Sayegh, MH, Frank, MH. Identification of cells initiating human melanomas. Nature. 2008;451:345–9.
28. Malanchi, I, Peinado, H, Kassen, D, Hussenet, T, Metzger, D, Chambon, P, Huber, M, Hohl, D, Cano, A, Birchmeier, W, Huelsken, J. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature. 2008;452:650–3.
29. Dean, M, Fojo, T, Bates, S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275–84.
30. Chen, J, Li, Y, Yu, TS, McKay, RM, Burns, DK, Kernie, SG, Parada, LF. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522–6.
31. Pang, R, Law, WL, Chu, AC, Poon, JT, Lam, CS, Chow, AK, Ng, L, Cheung, LW, Lan, XR, Lan, HY, Tan, VP, Yau, TC, Poon, RT, Wong, BC. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Stem Cell. 2010;6:603–15.
32. Malanchi, I, Santamaria-Martínez, A, Susanto, E, Peng, H, Lehr, HA, Delaloye, JF, Huelsken, J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481:85–9.
33. Mani, SA, Guo, W, Liao, MJ, Eaton, EN, Ayyan-an, A, Zhou, AY, Brooks, M, Reinhard, F, Zhang, CC, Shipitsin, M, Campbell, LL, Polyak, K, Brisken, C, Yang, J, Weinberg, RA. The epitheli-al-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.
34. Morel, AP, Lièvre, M, Thomas, C, Hinkal, G, An-sieau, S, Puisieux, A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008;3:e2888.
35. Vincan, E, Barker, N. The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorec-tal cancer progression. Clin Exp Metastasis. 2008;25:657–63.
36. Sánchez-Tilló, E, de Barrios, O, Siles, L, Cua-trecasas, M, Castells, A, Postigo, A. β-catenin/ TCF4 complex induces the epithelial-to-mes-enchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A. 2011;108:19204–9.
37. Scheel, C, Eaton, EN, Li, SH, Chaffer, CL, Re-inhardt, F, Kah, KJ, Bell, G, Guo, W, Rubin, J, Richardson, AL, Weinberg, RA. Paracrine and autocrine signals induce and maintain mesen-chymal and stem cell states in the breast. Cell. 2011;145:926–40.
38. Guo, W, Keckesova, Z, Donaher, JL, Shibue, T, Tischler, V, Reinhardt, F, Itzkovitz, S, Noske, A, Zürrer-Härdi, U, Bell, G, Tam, WL, Mani, SA, van Oudenaarden, A, Weinberg, RA. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012;148:1015–28.
39. Wellner, U, Schubert, J, Burk, UC, Schmalhofer, O, Zhu, F, Sonntag, A, Waldvogel, B, Vannier, C, Darling, D, zur Hausen, A, Brunton, VG, Morton, J, Sansom, O, Schüler, J, Stemmler, MP, Herz-berger, C, Hopt, U, Keck, T, Brabletz, S, Brabletz, T. The EMT-activator ZEB1 promotes tumori-genicity by repressing stemness-inhibiting mi-croRNAs. Nat Cell Biol. 2009;11:1487–95.
40. Shintani, Y, Okimura, A, Sato, K, Nakagiri, T, Kadota, Y, Inoue, M, Sawabata, N, Minami, M, Ikeda, N, Kawahara, K, Matsumoto, T, Matsuura, N, Ohta, M, Okumura, M. Epithelial to mesen-chymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg. 2011;92:1794–804.
41. Yang, AD, Fan, F, Camp, ER, van Buren, G, Liu, W, Somcio, R, Gray, MJ, Cheng, H, Hoff, PM, Ellis, LM. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006;12:4147–53.
42. Hoshino, H, Miyoshi, N, Nagai, K, Tomi-maru, Y, Nagano, H, Sekimoto, M, Doki, Y, Mori, M, Ishii, H. Epithelial-mesenchymal transition with expression of SNAI1-induced chemore-sistance in colorectal cancer. Biochem Bio-phys Res Commun. 2009;390:1061–5.
43. Celià-Terrassa, T, Meca-Cortés, O, Mateo, F, de Paz, AM, Rubio, N, Arnal-Estapé, A, Ell, BJ, Bermudo, R, Díaz, A, Guerra-Rebollo, M, Lo-zano, JJ, Estarás, C, Ulloa, C, Álvarez-Simón, D, Milà, J, Vilella, R, Paciucci, R, Martínez-Balbás, M, de Herreros, AG, Gomis, RR, Kang, Y, Blanco, J, Fernández, PL, Thomson, TM. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest. 2012;122:1849–68.
44. Ocaña, OH, Córcoles, R, Fabra, A, Moreno-Bue-no, G, Acloque, H, Vega, S, Barrallo-Gimeno, A, Cano, A, Nieto, MA. Metastatic colonization requires the repression of the epithelial-mesen-chymal transition inducer Prrx1. Cancer Cell. 2012;22:709–24.
45. Tsai, JH, Donaher, JL, Murphy, DA, Chau, S, Yang, J. Spatiotemporal regulation of epithe-lial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012;22:725–36.
46. Nieto, MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science. 2013;342:1234850.
47. McDonald, OG, Wu, H, Timp, W, Doi, A, Fein-berg, AP. Genome-scale epigenetic reprogram-ming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol. 2011;18:867–74.
48. Takahashi, K, Yamanaka, S. Induction of plu-ripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell. 2006;126:663–76.
49. Li, R, Liang, J, Ni, S, Zhou, T, Qing, X, Li, H, He, W, Chen, J, Li, F, Zhuang, Q, Qin, B, Xu, J, Li, W, Yang, J, Gan, Y, Qin, D, Feng, S, Song, H, Yang, D, Zhang, B, Zeng, L, Lai, L, Esteban, MA, Pei, D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear repro-gramming of mouse fbroblasts. Cell Stem Cell. 2010;7:51–63.
50. Liu, X, Sun, H, Qi, J, Wang, L, He, S, Liu, J, Feng, C, Chen, C, Li, W, Guo, Y, Qin, D, Pan, G, Chen, J, Pei, D, Zheng, H. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal re-programming. Nat Cell Biol. 2013;15:829–38.
51. Ben-Porath, I, Thomson, MW, Carey, VJ, Ge, R, Bell, GW, Regev, A, Weinberg, RA. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507.
52. Kawamura, T, Suzuki, J, Wang, YV, Menendez, S, Morera, LB, Raya, A, Wahl, GM, Izpisúa Bel-monte, JC. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009;460:1140–4.
53. Li, Q, Bohin, N, Wen, T, Ng, V, Magee, J, Chen, SC, Shannon, K, Morrison, SJ. Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature. 2013;504:143–7.
54. Scaffdi, P, Misteli, T. In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol. 2011;13:1051–61.
55. Barker, N, Ridgway, RA, van Es, JH, van de Wetering, M, Begthel, H, van den Born, M, Danenberg, E, Clarke, AR, Sansom, OJ, Clev-ers, H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608–11.
56. Schwitalla, S, Fingerle, AA, Cammareri, P, Neb-elsiek, T, Göktuna, SI, Ziegler, PK, Canli, O, Heijmans, J, Huels, DJ, Moreaux, G, Rupec, RA, Gerhard, M, Schmid, R, Barker, N, Clevers, H, Lang, R, Neumann, J, Kirchner, T, Taketo, MM, van den Brink, GR, Sansom, OJ, Arkan, MC, Greten, FR. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 2013;152:25–38.
57. Karin, M, Greten, FR. NF-κB: linking infam-mation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–59.
58. Bollrath, J, Greten, FR. IKK/NF-κB and STAT3 pathways: central signalling hubs in infamma-tion-mediated tumour promotion and metastasis. EMBO Rep. 2009;10:1314–9.
59. Polyak, K, Weinberg, RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265–73.
60. Caramel, J, Papadogeorgakis, E, Hill, L, Browne, GJ, Richard, G, Wierinckx, A, Saldanha, G, Os-borne, J, Hutchinson, P, Tse, G, Lachuer, J, Pui-sieux, A, Pringle, JH, Ansieau, S, Tulchinsky, E. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. 2013;24:466–80.
61. Stankic, M, Pavlovic, S, Chin, Y, Brogi, E, Padua, D, Norton, L, Massagué, J, Benezra, R. TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mes-enchymal-to-epithelial transition. Cell Rep. 2013;5:1228–42.
62. Gupta, GP, Perk, J, Acharyya, S, de Candia, P, Mittal, V, Todorova-Manova, K, Gerald, WL, Brogi, E, Benezra, R, Massagué, J. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A. 2007;104:19506–11.
63. Niola, F, Zhao, X, Singh, D, Castano, A, Sullivan, R, Lauria, M, Nam, HS, Zhuang, Y, Benezra, R, Di Bernardo, D, Iavarone, A, Lasorella, A. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat Cell Biol. 2012;14:477–87.
64. Niola, F, Zhao, X, Singh, D, Sullivan, R, Castano, A, Verrico, A, Zoppoli, P, Friedmann-Morvinski, D, Sulman, E, Barrett, L, Zhuang, Y, Verma, I, Benezra, R, Aldape, K, Iavarone, A, Lasorella, A. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. J Clin Invest. 2013;123:405–17.
65. Dykxhoorn, DM, Wu, Y, Xie, H, Yu, F, Lal, A, Petrocca, F, Martinvalet, D, Song, E, Lim, B, Li-eberman, J. miR-200 enhances mouse breast cancer cell colonization to form distant metas-tases. PLoS One. 2009;4:e7181.
66. Siemens, H, Jackstadt, R, Hünten, S, Kaller, M, Menssen, A, Götz, U, Hermeking H. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle. 2011;10:4256–71.
67. Reichert, M, Takano, S, von Burstin, J, Kim, SB, Lee, JS, Ihida-Stansbury, K, Hahn, C, Heeg, S, Schneider, G, Rhim, AD, Stanger, BZ, Rustgi, AK. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev. 2013;27:288–300.
68. Takahashi, Y, Sawada, G, Kurashige, J, Uchi, R, Matsumura, T, Ueo, H, Takano, Y, Akiyoshi, S, Eguchi, H, Sudo, T, Sugimachi, K, Doki, Y, Mori, M, Mimori, K. Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer. Br J Cancer. 2013;109:307–11.